EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018

Fanghua Li, Anbang Sun, Feng Wu, Dongshan Zhang, Zhanzheng Zhao

Frontiers in Cardiovascular Medicine · 09.02.2023 · 10

DOI: 10.3389/fcvm.2023.990997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 09.02.2023. Verfasst von Fanghua Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Blood pressure (BP) control rates among adult patients taking antihypertensive medications in the United States have not improved over the last decade. Many CKD adults require more than one class of antihypertensive agent to reach the BP target recommended by the guidelines. However, no study has quantified the proportion of adult CKD patients taking antihypertensive medication who are on monotherapy or combination therapy.

Methods

National Health and Nutrition Examination Survey data during 2001-2018 was used, including adults with CKD taking antihypertensive medication (age ≥ 20 years, n = 4,453). BP control rates were investigated under the BP targets recommended by the 2021 KDIGO, the 2012 KDIGO, and the 2017 ACC/AHA guidelines.

Results

The percentages of uncontrolled BP among US adults with CKD taking antihypertensive medication were 81.4% in 2001-2006 and 78.2% in 2013-2018. The proportion of monotherapy of antihypertensive regimen were 38.6, 33.3, and 34.6% from 2001 to 2006, 2007-2012, and 2013-2018, with no obvious difference. Similarly, there was no significant change in percentages of dual-therapy, triple-therapy, and quadruple-therapy. Although proportion of CKD adults not treated with ACEi/ARB decreased from 43.5% in 2001-2006 to 32.7% in 2013-2018, treatment of ACEi/ARB among patients with ACR > 300 mg/g had no significant change.

Conclusion

The BP control rates among US adult CKD patients taking antihypertensive medications have not improved from 2001 to 2018. Mono-therapy accounted for about one third of adult CKD patients taking antihypertensive medication and not changed. Increasing antihypertensive medication combination therapy may help improve BP control in CKD adults in the United States.

Schlagwörter

Stichwörter der Autor:innen

antihypertensive agentblood pressure (BP)chronic kidney diseaseclinical practice guidelineshypertension

Autor:innen und Institutionen

  • Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Anatomy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Emergency Medicine, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Emergency Medicine and Difficult Diseases Institute, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, F., Sun, A., Wu, F., Zhang, D., & Zhao, Z. (2023). Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.990997

Vancouver

Li F, Sun A, Wu F, Zhang D, Zhao Z. Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.990997

BibTeX
@article{Li2023,
  author = {Li, Fanghua and Sun, Anbang and Wu, Feng and Zhang, Dongshan and Zhao, Zhanzheng},
  title = {Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2023},
  volume = {10},
  doi = {10.3389/fcvm.2023.990997}
}
Kostenlos starten →